Search results
Uncovering Pfizer (PFE)'s True Value: A Comprehensive Analysis of Its Market Valuation
GuruFocus.com via Yahoo Finance· 8 months agoPfizer Inc (NYSE:PFE) recently experienced a daily gain of 4.13%, despite a 3-month loss of -9.96%....
Unveiling Pfizer (PFE)'s Value: Is It Really Priced Right? A Comprehensive Guide
GuruFocus.com via Yahoo Finance· 9 months agoPfizer Inc (NYSE:PFE) has experienced a daily gain of 3.37% and a 3-month loss of -7.09%. Despite...
Pharma Stock Roundup: EU Nod to PFE's Litfulo, FDA Priority Tag to MRK Applications
Zacks via Yahoo Finance· 9 months agoThe European Commission approves Pfizer's (PFE) Litfulo for severe alopecia areata. FDA gives...
Pfizer (PFE) Gains But Lags Market: What You Should Know
Zacks via Yahoo Finance· 2 years agoPfizer (PFE) closed at $43.65 in the latest trading session, marking a +1.84% move from the prior...
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
Zacks via Yahoo Finance· 1 month agoAstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer...
Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know
Zacks via Yahoo Finance· 11 months agoPfizer (PFE) closed at $36.02 in the latest trading session, marking a +0.95% move from the prior...
Pharma Stock Roundup: J&J New Buyback Plan, CHMP Nod to PFE's BA.4, BA.5 Omicron Jab
Zacks via Yahoo Finance· 2 years agoThis week, J&J JNJ announced plans to buy back $5 billion worth of shares and reaffirmed its profit...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo Finance· 1 week agoThis week, an FDA advisory committee unanimously recommended approval of Eli Lilly’s LLY Alzheimer's...
2 Undervalued High-Yield Names for High Total Returns
GuruFocus.com via Yahoo Finance· 9 months agoEven after some choppy weeks, the S&P 500 Index is still up more than 11% for 2023. But not all the...